De versnelling komt er aan.
New markets
The first two phases of the Group’s geographical expansion strategy are now completed. Operations in the new high-potential markets are already underway. In France, first strategic agreements were negotiated during the reporting period and will be signed in Q4. Operations and initial sales start to come from Germany, Belgium, Austria and Turkey. In Switzerland, Genoma is fully authorized and its non invasive prenatal test, Tranquility, is now accredited for reimbursement under the Swiss mandatory health insurance system. Poland, Romania and Ukraine are some of the new markets where Genoma is set to generate business starting in Q4.
Dit is ook een hele mooi zin....
"In Serbia, Genoma has become a market leader in a short period of time."